The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice

R Capasso, F Borrelli, J Zjawiony, L Kutrzeba, G Aviello, G Sarnelli, F Capasso, A A Izzo

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The hallucinogenic plant Salvia divinorum has been used for medical treatments of gastrointestinal disorders. Here, we evaluated the effect of a standardized extract from the leaves of Salvia divinorum (SDE) and of its active ingredient salvinorin A on motility in vivo, both in physiological states and during croton oil-induced intestinal inflammation. SDE (1-100 mg kg(-1)) significantly inhibited motility only in inflamed, but not in control, mice. In control mice, salvinorin A (0.01-10 mg kg(-1)) significantly inhibited motility only at the highest doses tested (3 and 10 mg kg(-1)) and this effect was not counteracted by naloxone or by the kappa-opioid receptor (KOR) antagonist nor-binaltorphimine. Inflammation significantly increased the potency of salvinorin A (but not of the KOR agonist U-50488) in reducing motility. The inhibitory effects of both salvinorin A and U-50488 in inflamed mice were counteracted by naloxone or by nor-binaltorphimine. We conclude that salvinorin A may reduce motility through activation of different targets. In physiological states, salvinorin A, at high doses, inhibited motility through a non-KOR mediated mechanism. Gut inflammation increased the potency of salvinorin A; this effect was mediated by KOR, but it was not shared by U-50488, thus suggesting that salvinorin A may have target(s) other than KOR in the inflamed gut.

Original languageEnglish
Pages (from-to)142-148
Number of pages7
JournalNeurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
Volume20
Issue number2
Early online date4 Sep 2007
DOIs
Publication statusPublished - Feb 2008

Fingerprint

salvinorin A
Salvia
Inflammation
kappa Opioid Receptor
(trans)-Isomer 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide
Naloxone
Croton Oil
Narcotic Antagonists
Opioid Receptors

Keywords

  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Analgesics, Non-Narcotic
  • Animals
  • Diterpenes
  • Diterpenes, Clerodane
  • Gastrointestinal Motility
  • Hallucinogens
  • Inflammation
  • Male
  • Mice
  • Mice, Inbred ICR
  • Plant Extracts
  • Plant Leaves
  • Receptors, Opioid, kappa
  • Salvia
  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this

The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice. / Capasso, R; Borrelli, F; Zjawiony, J; Kutrzeba, L; Aviello, G; Sarnelli, G; Capasso, F; Izzo, A A.

In: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, Vol. 20, No. 2, 02.2008, p. 142-148.

Research output: Contribution to journalArticle

@article{02094e82da6f48a5a652f828ae6a0500,
title = "The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice",
abstract = "The hallucinogenic plant Salvia divinorum has been used for medical treatments of gastrointestinal disorders. Here, we evaluated the effect of a standardized extract from the leaves of Salvia divinorum (SDE) and of its active ingredient salvinorin A on motility in vivo, both in physiological states and during croton oil-induced intestinal inflammation. SDE (1-100 mg kg(-1)) significantly inhibited motility only in inflamed, but not in control, mice. In control mice, salvinorin A (0.01-10 mg kg(-1)) significantly inhibited motility only at the highest doses tested (3 and 10 mg kg(-1)) and this effect was not counteracted by naloxone or by the kappa-opioid receptor (KOR) antagonist nor-binaltorphimine. Inflammation significantly increased the potency of salvinorin A (but not of the KOR agonist U-50488) in reducing motility. The inhibitory effects of both salvinorin A and U-50488 in inflamed mice were counteracted by naloxone or by nor-binaltorphimine. We conclude that salvinorin A may reduce motility through activation of different targets. In physiological states, salvinorin A, at high doses, inhibited motility through a non-KOR mediated mechanism. Gut inflammation increased the potency of salvinorin A; this effect was mediated by KOR, but it was not shared by U-50488, thus suggesting that salvinorin A may have target(s) other than KOR in the inflamed gut.",
keywords = "3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer, Analgesics, Non-Narcotic, Animals, Diterpenes, Diterpenes, Clerodane, Gastrointestinal Motility, Hallucinogens, Inflammation, Male, Mice, Mice, Inbred ICR, Plant Extracts, Plant Leaves, Receptors, Opioid, kappa, Salvia, Journal Article, Research Support, Non-U.S. Gov't",
author = "R Capasso and F Borrelli and J Zjawiony and L Kutrzeba and G Aviello and G Sarnelli and F Capasso and Izzo, {A A}",
year = "2008",
month = "2",
doi = "10.1111/j.1365-2982.2007.00994.x",
language = "English",
volume = "20",
pages = "142--148",
journal = "Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society",
issn = "1350-1925",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "2",

}

TY - JOUR

T1 - The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice

AU - Capasso, R

AU - Borrelli, F

AU - Zjawiony, J

AU - Kutrzeba, L

AU - Aviello, G

AU - Sarnelli, G

AU - Capasso, F

AU - Izzo, A A

PY - 2008/2

Y1 - 2008/2

N2 - The hallucinogenic plant Salvia divinorum has been used for medical treatments of gastrointestinal disorders. Here, we evaluated the effect of a standardized extract from the leaves of Salvia divinorum (SDE) and of its active ingredient salvinorin A on motility in vivo, both in physiological states and during croton oil-induced intestinal inflammation. SDE (1-100 mg kg(-1)) significantly inhibited motility only in inflamed, but not in control, mice. In control mice, salvinorin A (0.01-10 mg kg(-1)) significantly inhibited motility only at the highest doses tested (3 and 10 mg kg(-1)) and this effect was not counteracted by naloxone or by the kappa-opioid receptor (KOR) antagonist nor-binaltorphimine. Inflammation significantly increased the potency of salvinorin A (but not of the KOR agonist U-50488) in reducing motility. The inhibitory effects of both salvinorin A and U-50488 in inflamed mice were counteracted by naloxone or by nor-binaltorphimine. We conclude that salvinorin A may reduce motility through activation of different targets. In physiological states, salvinorin A, at high doses, inhibited motility through a non-KOR mediated mechanism. Gut inflammation increased the potency of salvinorin A; this effect was mediated by KOR, but it was not shared by U-50488, thus suggesting that salvinorin A may have target(s) other than KOR in the inflamed gut.

AB - The hallucinogenic plant Salvia divinorum has been used for medical treatments of gastrointestinal disorders. Here, we evaluated the effect of a standardized extract from the leaves of Salvia divinorum (SDE) and of its active ingredient salvinorin A on motility in vivo, both in physiological states and during croton oil-induced intestinal inflammation. SDE (1-100 mg kg(-1)) significantly inhibited motility only in inflamed, but not in control, mice. In control mice, salvinorin A (0.01-10 mg kg(-1)) significantly inhibited motility only at the highest doses tested (3 and 10 mg kg(-1)) and this effect was not counteracted by naloxone or by the kappa-opioid receptor (KOR) antagonist nor-binaltorphimine. Inflammation significantly increased the potency of salvinorin A (but not of the KOR agonist U-50488) in reducing motility. The inhibitory effects of both salvinorin A and U-50488 in inflamed mice were counteracted by naloxone or by nor-binaltorphimine. We conclude that salvinorin A may reduce motility through activation of different targets. In physiological states, salvinorin A, at high doses, inhibited motility through a non-KOR mediated mechanism. Gut inflammation increased the potency of salvinorin A; this effect was mediated by KOR, but it was not shared by U-50488, thus suggesting that salvinorin A may have target(s) other than KOR in the inflamed gut.

KW - 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer

KW - Analgesics, Non-Narcotic

KW - Animals

KW - Diterpenes

KW - Diterpenes, Clerodane

KW - Gastrointestinal Motility

KW - Hallucinogens

KW - Inflammation

KW - Male

KW - Mice

KW - Mice, Inbred ICR

KW - Plant Extracts

KW - Plant Leaves

KW - Receptors, Opioid, kappa

KW - Salvia

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1111/j.1365-2982.2007.00994.x

DO - 10.1111/j.1365-2982.2007.00994.x

M3 - Article

VL - 20

SP - 142

EP - 148

JO - Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society

JF - Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society

SN - 1350-1925

IS - 2

ER -